PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study
NCT03686332
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Penile Cancer
Interventions
DRUG:
Arm A: Atezolizumab and Radiotherapy
DRUG:
Arm B: Atezolizumab
Sponsor
The Netherlands Cancer Institute
Collaborators
[object Object]